Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Amyloidosis

Amyloidosis

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Amyloidosis

15 trials tracked for Amyloidosis: 5 in phase 3 or 4 and 5 with published results. The most-cited published study has 1440 citations.

15Trials tracked
5Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 3 5 Phase 2 7 Other / NA 3
  1. Phase 3 Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy Completed · 1,440 cited
  2. Phase 3 A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis Completed · 687 cited
  3. Phase 3 The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran) Completed · 161 cited
  4. Phase 3 Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP) Completed · 72 cited
  5. Phase 3 Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy Completed · 7 cited
  6. Phase 2 Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis Completed
Show 9 more trials
  1. Phase 2 A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis Completed
  2. Phase 2 Ixazomib Rollover Study Completed
  3. Phase 2 A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis Completed
  4. Phase 2 Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis Completed
  5. Phase 2 Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis Completed
  6. Phase 2 Safety and Effect of Doxycycline in Patients With Amyloidosis Completed
  7. N/A Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease Completed
  8. N/A Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis Completed
  9. N/A A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.